Last reviewed · How we verify

NCT06267378

Assessing Frailty and Its Impacts on Patients Facing Major GI Surgery

Recruiting now Last updated 8 July 2024
What this trial tests

trial testing Frailty measure in Bowel Cancer in 100 participants. Currently enrolling.

Timeline
30 August 2023
Primary endpoint
1 December 2024
1 December 2029

Quick facts

Lead sponsorDoncaster And Bassetlaw Hospitals NHS Foundation Trust
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date30 August 2023
Primary completion1 December 2024
Estimated completion1 December 2029
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Doncaster And Bassetlaw Hospitals NHS Foundation Trust

Who can join

18 and older, any sex, with Bowel Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study team will look at 3 new tests that will make it easier to measure frailty in patients awaiting surgery for cancer and compare them against standard clinical measures of frailty in a pilot study. The expected outcome is that evidence will be collated in order to apply for a major grant to look at improving the care of frail patients with cancer in the future.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Doncaster And Bassetlaw Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06267378.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing